5-amino-1MQ Reference

Plain English

What it is

5-amino-1MQ is a lab-made small molecule, not a peptide. It blocks an enzyme in the body called NNMT. It is not approved by the FDA as a drug, and it is sold only as a research chemical.

What people use it for

People in the fat-loss and body-composition crowd talk about it as a way to drop body fat. These uses are not proven in people and come from marketing and personal stories, not from approved medical guidance.

What the science shows

Almost all of the evidence comes from studies in obese mice, where blocking NNMT lowered body weight and body fat without changing how much the animals ate. There is no published human clinical trial showing 5-amino-1MQ works or is safe in people.

The catch

Because there are no human trials, the real effects, the safe amounts, and the long-term safety in people are all unknown. Animal results often do not carry over to humans, especially in weight research, so any fat-loss claims should be treated as unproven.

Reference summary

Published work is preclinical, focused on NNMT-inhibition mechanisms and rodent diet-induced-obesity models. There is no published human clinical program at the time of review.

Regulatory and posture

Categories

Metabolic, Fat Loss

Aliases

5-amino-1-methylquinolinium, NNMT inhibitor, Non-peptide small molecule

Evidence posture

preclinical - Preclinical rodent data only. There is no published human clinical program for 5-amino-1MQ, and NNMT inhibition as a weight-loss strategy has not been validated in humans.

Regulatory status

No FDA-approved 5-amino-1MQ drug label. 5-amino-1MQ is a non-peptide small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied in rodent models of diet-induced obesity.

Content review status

research reference